Very good point. Inspired by your comment, I took another look at the deal from two different angles:
Board Perspective - the loan that offsets the risk of stage 2 placement not being approved demonstrates that the whole deal was structured with a long-term commitment in mind. The 12-month term indicates that the Board was looking for a pathway to keep the project moving, rather than just focusing on the placement itself.
Hebang Perspective - before the deal was struck, AEV had been sitting around a $10M market cap for a while. A loan that represents a 30% ratio of the market cap? Normally, you'd expect a big player like Hebang to insist on demanding security on the asset. Their willingness to offer it as an unsecured loan for 12 months is quite telling. This is a strong signal of their confidence in the value of the company, beyond just targeting the project asset.
- Forums
- ASX - By Stock
- Ann: Strategic Investment from Sichuan Hebang Biotechnology
Very good point. Inspired by your comment, I took another look...
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AEV (ASX) to my watchlist
|
|||||
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $32.44M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.1¢ | $12.12K | 1.010M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 594315 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 1700000 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 594315 | 0.012 |
12 | 3660283 | 0.011 |
5 | 4245002 | 0.010 |
7 | 4617722 | 0.009 |
7 | 2117999 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 1700000 | 5 |
0.014 | 3023982 | 9 |
0.015 | 3024172 | 10 |
0.016 | 11160352 | 15 |
0.017 | 2816529 | 7 |
Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
Featured News
AEV (ASX) Chart |